Prospera Financial Services’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $229K | Sell |
1,806
-643
| -26% | -$81.4K | ﹤0.01% | 1218 |
|
2025
Q1 | $313K | Sell |
2,449
-284
| -10% | -$36.3K | 0.01% | 974 |
|
2024
Q4 | $361K | Sell |
2,733
-147
| -5% | -$19.4K | 0.01% | 857 |
|
2024
Q3 | $419K | Buy |
2,880
+152
| +6% | +$22.1K | 0.01% | 782 |
|
2024
Q2 | $374K | Sell |
2,728
-482
| -15% | -$66.2K | 0.01% | 824 |
|
2024
Q1 | $440K | Buy |
3,210
+428
| +15% | +$58.7K | 0.01% | 745 |
|
2023
Q4 | $378K | Sell |
2,782
-466
| -14% | -$63.3K | 0.01% | 749 |
|
2023
Q3 | $397K | Buy |
3,248
+1,406
| +76% | +$172K | 0.02% | 688 |
|
2023
Q2 | $234K | Sell |
1,842
-82
| -4% | -$10.4K | 0.01% | 903 |
|
2023
Q1 | $249K | Sell |
1,924
-225
| -10% | -$29.1K | 0.01% | 843 |
|
2022
Q4 | $282K | Sell |
2,149
-138
| -6% | -$18.1K | 0.01% | 735 |
|
2022
Q3 | $267K | Sell |
2,287
-229
| -9% | -$26.7K | 0.01% | 686 |
|
2022
Q2 | $296K | Sell |
2,516
-87
| -3% | -$10.2K | 0.02% | 639 |
|
2022
Q1 | $339K | Sell |
2,603
-341
| -12% | -$44.4K | 0.01% | 713 |
|
2021
Q4 | $449K | Sell |
2,944
-324
| -10% | -$49.4K | 0.02% | 606 |
|
2021
Q3 | $529K | Sell |
3,268
-321
| -9% | -$52K | 0.03% | 519 |
|
2021
Q2 | $588K | Buy |
3,589
+6
| +0.2% | +$983 | 0.03% | 487 |
|
2021
Q1 | $540K | Sell |
3,583
-767
| -18% | -$116K | 0.03% | 470 |
|
2020
Q4 | $659K | Buy |
4,350
+3,134
| +258% | +$475K | 0.05% | 367 |
|
2020
Q3 | $165K | Sell |
1,216
-2,324
| -66% | -$315K | 0.06% | 279 |
|
2020
Q2 | $484K | Buy |
3,540
+937
| +36% | +$128K | 0.04% | 358 |
|
2020
Q1 | $281K | Buy |
+2,603
| New | +$281K | 0.03% | 406 |
|
2019
Q1 | – | Sell |
-3,706
| Closed | -$359K | – | 374 |
|
2018
Q4 | $359K | Buy |
3,706
+1,859
| +101% | +$180K | 0.07% | 253 |
|
2018
Q3 | $215K | Buy |
+1,847
| New | +$215K | 0.04% | 379 |
|
2017
Q1 | – | Sell |
-3,306
| Closed | -$297K | – | 402 |
|
2016
Q4 | $297K | Buy |
+3,306
| New | +$297K | 0.06% | 273 |
|